Recurrent Urinary Tract Infections and Heparin (RUTIH Trial)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Recurrent Urinary Tract Infections
Interventions
DRUG

Intravesical Heparin

Heparin bladder instillation

OTHER

Placebo

Intravesical saline

Trial Locations (1)

74135

RECRUITING

University of Oklahoma-Tulsa OB/GYN Dept and OU-Physicians, Tulsa

All Listed Sponsors
lead

University of Oklahoma

OTHER